Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Novartis selects analgesic agent as clinical candidate

Jan. 28, 1997

New psychopharmacological agents developed by Ferrer

Jan. 28, 1997

Spotlight on CCK-B antagonists for anxiety

Jan. 27, 1997

Medeva begins full development of ADHD Rx

Jan. 27, 1997

NK1 antagonists from Takeda

Jan. 27, 1997

Excitatory amino acid receptor ligands from Schering AG

Jan. 27, 1997

FDA approves Royce's generic narcotic pain reliever

Jan. 24, 1997

Royce Laboratories receives FDA approval for alprazolam

Jan. 24, 1997

SIBIA receives patent coverage for antiparkinson compounds

Jan. 24, 1997

Glaxo Wellcome selects anticonvulsant compound for further study

Jan. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...